Beam Therapeutics Inc 10-Q for FY2023 Q2
Beam Therapeutics Inc. (BEAM)
10-Q
2023-08-08
For: 2023-06-30
View Original
Added on
April 09, 2026
About this 10-Q
Beam Therapeutics Inc filed this 10-Q on August 8, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).
Headline figures
Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $20.12M
- up 20.8% from $16.65M a year earlier
- Net loss
- $82.78M
- compared with a net loss of $71.95M a year earlier
- Diluted EPS
- -$1.08
- compared with -$1.02 a year earlier